Figure 2.

Curcumin inhibits the proliferation of triple-negative breast cancer. (a) In vivo bioluminescence imaging of the breast cancer-bearing mice on day 0, day 14, and day 28 after intervention (n = 6/group). (b) Statistical analysis of bioluminescence value of tumor-bearing mice on day 0, day 14, and day 28 after intervention (n = 6/group). (c) Comparison of in situ tumor morphology between tumor-bearing model mice and curcumin treatment mice. (d) Model group and curcumin treatment group tumor growth curve during the intervention period (n = 8/group). (e, f) Statistical analysis of terminal tumor volume and bodyweight in the model group and the curcumin group (n = 8/group). NS: not significant; ^∗p < 0.05 and ^∗∗p < 0.01 by t-test, compared to the model group. Data were shown as mean ± standard errors of the mean.